Abstract
Background: Multidisciplinary decision-making in head and neck cancer care is complex and requires a tradeoff between prolonging survival and optimizing quality of life. To support prognostication and decision-making in head and neck cancer care, an individualized prognostic model for overall survival (OncologIQ) is available. Methods: By quantitative and qualitative research we have studied user value of OncologIQ and its impact on the decision-making process in a multidisciplinary consultation meeting. Results: Healthcare professionals experienced added value upon using prognostic estimates of survival from OncologIQ in half (47.5%) of the measurements. Significant impact on the decision making process was seen when OncologIQ was used for older patients, patients having a WHO performance score ≥ 2, or high tumor stage. Conclusions: The prognostic model OncologIQ enables patient-centered decision-making in a multidisciplinary consultation meeting and was mostly valued in complex patients.
Original language | English |
---|---|
Pages (from-to) | 2481-2490 |
Number of pages | 10 |
Journal | Head and Neck |
Volume | 44 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2022 |
Bibliographical note
Funding Information:This research partly received funding from the National Health Care Institute (Zorginstituut Nederland).
Publisher Copyright:
© 2022 The Authors. Head & Neck published by Wiley Periodicals LLC.